Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000519906 | SCV000618698 | uncertain significance | not provided | 2017-06-29 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the NEB gene. The T5893A variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The T5893A variant is observed in 5/66,726 (0.007%) alleles from individuals of European background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The T5893A variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Invitae | RCV000558674 | SCV000640603 | uncertain significance | Nemaline myopathy 2 | 2016-12-20 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000558674 | SCV001454701 | uncertain significance | Nemaline myopathy 2 | 2020-03-10 | no assertion criteria provided | clinical testing |